NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»18/10/2009 [Industry news]
China Pediatric Completes a Reverse Merger

China Peadiatric Pharmaceuticals, Inc. (LHSI.OB) has completed a reverse merger, taking over the company formerly known as Lid Hair Studios International. China Pediatric Pharma, which is headquartered in Xi’an, produces and distributes prescription and OTC drugs for children, some of which are western and the rest based on TCM.

 
China Peadiatric Pharmaceuticals, Inc. (LHSI.OB) has completed a reverse merger, taking over the company formerly known as Lid Hair Studios International. China Pediatric Pharma, which is headquartered in Xi’an, produces and distributes prescription and OTC drugs for children, some of which are western and the rest based on TCM. The company reported $7.1 million in revenue for the six months of 2009 and $1.6 million in net income. The net income is equivalent to 19 cents per share. In China, the company’s operating subsidiary is Shaanxi Jiali Pharmaceutical Company, which produces 13 products in its own facility and sells an additional 13 products manufactured by OEM companies. The products are marketed under three brands: Cooer, Xianzhi and Qingsongling. In an SEC filing, China Pediatric said an additional five products await SFDA approval. The company has already changed its name to China Pediatric Pharmaceuticals, though its symbol will remain LHSI for the near-term. China Pediatric has 8.2 million shares outstanding. At the current price of $1.55 per share, the company has a market capitalisation of $13 million.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.